Treatment of Primary FSGS in AdultsKORBET, Stephen M.Journal of the American Society of Nephrology. 2012, Vol 23, Num 11, pp 1769-1776, issn 1046-6673, 8 p.Article

Functional Decline in Older Patients With Cancer Receiving First-Line ChemotherapyHOPPE, Stéphanie; RAINFRAY, Muriel; VOGT, Luc et al.Journal of clinical oncology. 2013, Vol 31, Num 31, pp 3877-3882, issn 0732-183X, 6 p.Article

First-Line Chemotherapy of Disseminated Germ Cell TumorsNICHOLS, Craig; KOLLMANNSBERGER, Christian.Hematology/oncology clinics of North America. 2011, Vol 25, Num 3, issn 0889-8588, viii, 543-556 [15 p.]Article

Immunoglobulin treatment in primary antibody deficiencyMAARSCHALK-ELLERBROEK, L. J; HOEPELMAN, I. M; ELLERBROEK, P. M et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 5, pp 396-404, issn 0924-8579, 9 p.Article

Managing newly diagnosed follicular lymphoma: state of the art and future perspectivesLI, Zhi-Ming; GHIELMINI, Michele; MOCCIA, Alden A et al.Expert review of anticancer therapy. 2013, Vol 13, Num 3, pp 313-325, issn 1473-7140, 13 p.Article

Long-Term Efficacy and Safety of Arsenic Trioxide for First-Line Treatment of Elderly Patients With Newly Diagnosed Acute Promyelocytic LeukemiaYINGMEI ZHANG; ZHUO ZHANG; YING ZHANG et al.Cancer. 2013, Vol 119, Num 1, pp 115-125, issn 0008-543X, 11 p.Article

Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: A dose escalation studyBONNETERRE, Jacques; TUBIANA-HULIN, Michèle; CATIMEL, Gilles et al.Oncology. 2004, Vol 66, Num 3, pp 185-191, issn 0030-2414, 7 p.Article

Initiation of hypertension treatment with a fixed-dose combination or its monocomponents : does it really matter?SCHOLZE, J; BIDA, M; HANSEN, A et al.International journal of clinical practice (Esher). 2006, Vol 60, Num 3, pp 265-274, issn 1368-5031, 10 p.Article

First-line Bevacizumab plus Taxane-based Chemotherapy for Metastatic Breast Cancer: Cost-minimisation AnalysisNERICH, Virginie; BAZAN, Fernando; COMPAGNAT, Fanny et al.Anticancer research. 2012, Vol 32, Num 8, pp 3547-3552, issn 0250-7005, 6 p.Article

Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in AdultsWILBY, Kyle John; ENSOM, Mary H. H; MARRA, Fawziah et al.Clinical pharmacokinetics. 2014, Vol 53, Num 10, pp 873-890, issn 0312-5963, 18 p.Article

Review article: cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosisCAMPBELL, H. E; ESCUDIER, M. P; PATEL, P et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 7, pp 687-701, issn 0269-2813, 15 p.Article

First-line therapy for chronic myeloid leukemia : past, present, and futurePAVLOVSKY, Carolina; KANTARJIAN, Hagop; CORTES, Jorge E et al.American journal of hematology. 2009, Vol 84, Num 5, pp 287-293, issn 0361-8609, 7 p.Article

HTA: Diurétique d'abord (suite) = First-line treatment of hypertensive patients with diureticsLa Revue Prescrire. 2003, Vol 23, Num 242, issn 0247-7750, p. 618Article

Percutaneous Lavage as Primary Treatment for Infected Pancreatic NecrosisSLEEMAN, Danny; LEVI, David M; LIVINGSTONE, Alan S et al.Journal of the American College of Surgeons. 2011, Vol 212, Num 4, pp 748-752, issn 1072-7515, 5 p.Article

Current Prospects for the Fluoroquinolones as First-Line Tuberculosis TherapyTAKIFF, Howard; GUERRERO, Elba.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5421-5429, issn 0066-4804, 9 p.Article

Recovery and self-management support following primary cancer treatmentFOSTER, C; FENION, D.British journal of cancer. 2011, Vol 105, issn 0007-0920, S21-S28, SUP1Article

Should Progressive Perineal Dilation be Considered First Line Therapy for Vaginal Agenesis? Commentary. Author's replyGARGOLLO, Patricio C; CANNON, Glenn M; DIAMOND, David A et al.The Journal of urology. 2009, Vol 182, Num 4, pp 1882-1891, issn 0022-5347, 10 p., 2Conference Paper

Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian PatientsTOSTMANN, Alma; MTABHO, Charles M; SEMVUA, Hadija H et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 7, pp 3208-3213, issn 0066-4804, 6 p.Article

Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for CancerSOUBEYRAN, Pierre; FONCK, Marianne; ANDRIAMAMPIONONA, Francis et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1829-1834, issn 0732-183X, 6 p.Article

The Interface of Primary and Oncology Specialty Care: From Diagnosis Through Primary TreatmentSUSSMAN, Jonathan; BALDWIN, Laura-Mae.Journal of the National Cancer Institute. Monographs. 2010, Vol 40, pp 18-24, issn 1052-6773, 7 p.Article

The Interface Between Primary and Oncology Specialty Care: Treatment Through SurvivorshipGRUNFELD, Eva; EARLE, Craig C.Journal of the National Cancer Institute. Monographs. 2010, Vol 40, pp 25-30, issn 1052-6773, 6 p.Article

Front-line immunosuppressive treatment of acquired aplastic anemia : Treatment and Hematopoietic Stem Cell Transplantation in Aplastic AnemiaDUFOUR, C; SVAHN, J; BACIGALUPO, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, pp 174-177, issn 0268-3369, 4 p.Article

Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. CommentaryGUILHOT, Francois; HEHLMANN, Rüdiger; REITER, Andreas et al.Blood. 2007, Vol 109, Num 11, issn 0006-4971, 4592, 4686-4692 [8 p.]Article

Treating Patients With EGFR-Sensitizing Mutations: First Line or Second Line—Is There a Difference?MOK, Tony; YANG, Jin-Ji; LAM, Kwok-Chi et al.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1081-1088, issn 0732-183X, 8 p.Article

Traitement de première ligne chez le sujet âgéDARTIGEAS, C.Correspondances en onco-hématologie. 2009, Num JUIL, pp 12-15, issn 1954-4820, 4 p., NSArticle